Page last updated: 2024-10-26

disulfiram and Cancer of Eye

disulfiram has been researched along with Cancer of Eye in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brar, SS1
Grigg, C1
Wilson, KS1
Holder, WD1
Dreau, D1
Austin, C1
Foster, M1
Ghio, AJ1
Whorton, AR1
Stowell, GW1
Whittall, LB1
Whittle, RR1
White, DP1
Kennedy, TP1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Phase II Open Labeled Trial of Disulfiram With Copper in Metastatic Breast Cancer[NCT03323346]Phase 2150 participants (Anticipated)Interventional2017-09-29Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

1 other study available for disulfiram and Cancer of Eye

ArticleYear
Disulfiram inhibits activating transcription factor/cyclic AMP-responsive element binding protein and human melanoma growth in a metal-dependent manner in vitro, in mice and in a patient with metastatic disease.
    Molecular cancer therapeutics, 2004, Volume: 3, Issue:9

    Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Copper; Cyclic AMP Response El

2004